Amiodarone-Induced Interstitial Pneumonia: A Cause of Respiratory Failure
Author Information
Author(s): Muacevic Alexander, Adler John R, Eusébio Sofia, Soares Ana Raquel, Fiúza Pedro, Garcia Teresa
Primary Institution: Hospital de Santa Marta, Unidade Local de Saúde São José, Lisbon, PRT
Hypothesis
Is amiodarone-induced interstitial pneumonia a preventable cause of respiratory failure in patients undergoing antiarrhythmic therapy?
Conclusion
Amiodarone-induced interstitial pneumonia is a critical but preventable cause of respiratory failure that can improve with timely diagnosis and management.
Supporting Evidence
- Amiodarone is effective for managing various types of cardiac arrhythmias.
- Pulmonary toxicity from amiodarone is rare but can lead to serious complications.
- Timely diagnosis and management of amiodarone-induced interstitial pneumonia can improve patient outcomes.
Takeaway
Amiodarone can cause serious lung problems in some patients, but stopping the medication and using steroids can help them feel better.
Methodology
The case study reports on an 89-year-old female patient with chronic amiodarone use who developed respiratory failure, diagnosed through clinical, radiological, and histological data.
Potential Biases
Potential bias in reporting due to the nature of a single case study.
Limitations
The study is based on a single case report, limiting generalizability.
Participant Demographics
An 89-year-old female patient with a history of heart failure and atrial flutter.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website